Skip to content

Clinical trials

Phase 2 Mesothelioma, Malignant trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Phase: Phase 2 Status: Unknown status Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20061
20092
20111
20121
20152
20162
20191
20201
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Azienda Ospedaliera Universitaria Senese2
Ain Shams University1
Barts & The London NHS Trust1
British Thoracic Society1
Columbia University1
European Organisation for Research and Treatment of Cancer - EORTC1
Herbert Irving Comprehensive Cancer Center1
Hospices Civils de Lyon1
Italian Network for Tumor Biotherapy Foundation1
Jules Bordet Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant16
Carcinoma, Non-Small-Cell Lung2
Breast Neoplasms1
Carcinoma, Hepatocellular1
Carcinoma, Merkel Cell1
Carcinoma, Renal Cell1
Gastrointestinal Neoplasms1
Head and Neck Neoplasms1
Melanoma1
Mesothelioma1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.